Introduction
Bacteroides fragilis, an extracellular gram-negative anaerobe accounting for the majority of positive anaerobic blood cultures, is a common isolate from intraabdominal abscesses, particularly abscesses arising from a colonic source (1) . Experimental work, first in a rat and later in a mouse model, has established that T cells, rather than antibody, are responsible for immunity to intraabdominal abscesses induced by the organism (2, 3). These T cells were characterized further as suppressor cells by phenotype (3) . This paper presents evidence that in addition to immune T cells, a cell-free immune T cell factor (ITF) ' an immune splenic T cell population protects experimental animals from developing intraabdominal abscesses caused by B. fragilis. Preliminary purification of this factor reveals that the active material is low in molecular weight, can bind to B. fragilis capsular polysaccharide (CP), and induces antigenspecific immunity to abscesses. The material is heat-labile and loses efficacy after protease, but not nuclease, digestion.
Methods
Bacterial strains. B. fragilis (no. 23745; American Type Culture Collection, Rockville, MD) and Bacteroides distasonis (no. 8503; American Type Culture Collection) were employed from the stock collection of the Channing Laboratory, Boston, MA. Fusobacterium varium (TVDL 37) was obtained from the stock culture collection of the Tufts University Veterinary Diagnostic Laboratory, Jamaica Plains, MA. Streptococcusfaecalis (enterococcus) 2988T was a urinary clinical isolate from the Bacteriology Laboratory, Beth Israel Hospital, Boston, MA. Anaerobes were incubated in prereduced peptone yeast glucose medium (Scott Laboratories, Fiskeville, RI) within an anaerobic isolator (Lab-Line Instruments, Melrose Park, IL) for 24-48 h and frozen in 5-ml aliquots in gas tight vials at -70'C. The enterococcus was grown in Todd Hewitt broth (Difco Laboratories, Detroit, MI) incubated for 24 h at 370C and frozen in the same manner.
Mice. C57BL6 male mice were purchased from The Jackson Laboratory (Bar Harbor, ME). All animals were screened on arrival by serology for active murine virus infection and were housed in cages containing no more than 10 animals. They were given Purina mouse chow (Ralston Purina Co., St. Louis, MO) and water ad libitum, and were from 6 to 10 wk of age at the time of experiments.
Mouse immunization. CP antigen of B. fragilis 23745 was isolated and purified by methods previously described (4) . Mice were immunized with 10 gg of antigen in 0.1 ml phosphate-buffered saline (PBS) subcutaneously three times a week for 3 wk and were utilized in experiments during the fourth week after immunization was initiated.
Spleen cell preparations. Spleens from immunized or nonimmunized mice were removed by blunt dissection, gently teased apart, and ground over a wire mesh screen. Cell suspensions in balanced salt solution (BSS) with 5% fetal calf serum (FCS) (M. A. Bioproducts, Walkersville, MD) were counted by trypan blue dye exclusion after filtering through glass wool. Nylon wool column processing. Nylon wool columns were utilized to obtain T cell-enriched spleen cell suspensions. Methods employed here have been described previously (2).
Factor preparation. Lysates of T cell-enriched fractions from both immunized and nonimmunized mice were prepared by serial freezethawing known concentrations of cells. Suspensions containing 2.5 X 10' cells/ml were shell-frozen with dry ice and alcohol, and then, thawed for several minutes in a boiling water bath, without warming the solution, sequentially four times. Debris was filtered out by passage over glass wool, and the volume returned to starting volume with BSS and 5% FCS. l-ml aliquots were stored at -80°C. Table III. Mice receiving nondialyzed ITF were protected from developing abscesses caused by B. fragilis. Animals not receiving ITF all developed abscesses. The active component of the lysate appeared to be smaller than 12,000 mol wt since the dialysis bag contents lost protective capacity, while the dialysate was protective despite a 30-fold dilution from the initial volume of 1 ml.
The T cell lysate was purified partially by molecular sieve chromatography. ITF was loaded initially on an S-200 column and pooled fractions tested for protective activity in mice. In multiple runs, protection was conferred by fractions near and at the bed volume of the column (data not shown). A protective peak which eluted at 26 ml from the S-200 column (where 12 ml represented void volume and 43 ml bed volume) was placed on a P2 Biogel column. 2-ml fractions from the P2 Biogel column were pooled as marked on the elution profile recorded by RI monitoring (Fig. 1) . The P2 Biogel column has an exclusion size of 1,800 mol wt for proteins. Doses of 0.2 cm3 of these pooled fractions were transferred to mice which were challenged and examined for abscesses. Partial characterization of column-purified ITF. Columnpurified ITF was evaluated for heat stability by incubating previously active P2 Biogel column fractions at different temperatures and injecting the fractions into mice to assess protective efficacy against abscesses. A control sample was incubated at 4VC since activity had been preserved at this temperature during the column chromatography processing. lability of column-purified ITF indicates that the active component was not antibody. To determine whether the active constituent of ITF was a protein or nucleic acid, factor was subjected to enzyme digestion with either pronase or trypsin, or with the nucleases, DNase and RNase. Based on the previous experiment, enzyme digestions were performed at room temperature for 2.5 h. After 2 h, trypsin soybean inhibitor was added to the trypsin tube to neutralize enzyme activity. To avoid manipulating ITF excessively but to remove the enzymes before injecting mice, ITF was dialyzed as before and 0.2 cm3 of dialysate was transferred to mice. The enzymes were retained in the dialysis bags. Control ITF was processed in an identical fashion without enzyme and also was dialyzed. Results appear in Table VII. Mice not receiving factor all formed abscesses, while dialysate of ITF without enzyme treatment was protective. DNase/ RNase treatment did not alter protection. Both pronase and trypsin digestion, however, eliminated the protective effect of ITF against abscesses caused by B.fragilis (P < 0.001 compared with ITF). These results suggest that ITF is a protein or, alternatively, that activity depends on a protein cofactor.
Discussion
Despite conventional teaching that host defense to extracellular bacteria involves humoral factors usually in conjunction with phagocytic cells, we have found that immunity to experimental intraabdominal abscesses caused by the "extracellular" pathogen B. fragilis is T cell-dependent. The T cells have been defined further as suppressor by phenotype (3) . In this report we demonstrate that a cell-free factor derived from splenic T cells from mice immunized with B. fragilis CP protects animals against abscesses caused by this organism as effectively as intact T cells. This cell-free lysate (ITF) appears to be small in size since protective activity is dialyzable through a 12,000-mol wt dialysis membrane, and after column chromatography, protection is mediated by fractions intermediate between the void volume and bed volume of a P2 Biogel column, possibly suggesting a size < 1,800 D. 1,800 D represents the exclusion size for proteins on the P2 Biogel column. The broad protective Characterization of this factor is hampered by the lability of its activity. Column-purified ITF is not heat-stable and, in fact, loses its protective effect upon heating to 370C for 30 min. The apparent size of the material and its heat-lability both indicate that the active constituent of ITF is not antibodylike. Enzyme digestion by both the nonspecific protease, pronase, and by trypsin removed the ability of ITF to protect against abscesses. Digestion with DNase/RNase did not affect protection. ITF appears then to be a protein or at least to depend on a protein cofactor in the preparation.
Recent literature is replete with the definition and partial characterization of a number of cellular factors from both helper and suppressor T cell populations (8) (9) (10) . Beginning with dialyzable activity from lymph node cell populations containing transfer factor, investigators have defined both antigen-specific and nonspecific regulatory phenomena mediated by cellular factors (8) . Though like transfer factor, ITF appears to be low in molecular weight and labile, its activity seems to be exclusively antigen-specific and trypsin-sensitive. (9, 12) . Our system provides a biological model closely resembling human disease, which differentiates this model from others. We, however, have not defined a discrete suppressive activity of ITF despite the suppressor-like nature of the originating T cells. Others have described antigen-specific suppressor factors which trigger other cells which, in turn, release nonspecific inhibitory factors (13, 14) . Injection of cryptococcal antigen into mice stimulates a suppressor T cell lymph node population (14) . A soluble factor derived from these lymph node cells, in turn, stimulates a splenic suppressor T cell population which has been found to suppress the delayed type hypersensitivity response to the inciting antigen (14) . Similar T cell circuits have been defined in response to inert haptens (12 
